- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IND Swift Laboratories Ltd (ISLB)
Track today's live Ind-Swift Labs (ISLB) share price, performance and key data on this page with our current NSE:ISLB stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Ind-Swift Labs share price on the NSE exchange. Use the dropdown to switch exchange for the ISLB share price, head to our technical summary section, which provides analysis on Ind-Swift Labs share price buy/sell indicators using real-time data (or discuss the Ind-Swift Labs (ISLB) stock price today with other investors in the Ind-Swift Labs NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:ISLB share price (ISIN: INE915B01019) to enhance your trading decisions with our free investment tools and resources.
What Is the IND Swift Laboratories Ltd Share Price Today?
The Ind-Swift Labs share price today is 355.95.
What Is the Stock Symbol for IND Swift Laboratories Ltd
The stock symbol (or 'ticker') for IND Swift Laboratories Ltd is "ISLB."
What Stock Exchange Does IND Swift Laboratories Ltd Trade On?
IND Swift Laboratories Ltd is listed and trades on the NSE stock exchange.
Is IND Swift Laboratories Ltd a Good Stock to Buy?
Determining whether Ind-Swift Labs (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:ISLB share price (ISIN: INE915B01019) to enhance your trading decisions with our free investment tools and resources.
What Is the IND Swift Laboratories Ltd Share Price Today?
The Ind-Swift Labs share price today is 355.95.
What Is the Stock Symbol for IND Swift Laboratories Ltd
The stock symbol (or 'ticker') for IND Swift Laboratories Ltd is "ISLB."
What Stock Exchange Does IND Swift Laboratories Ltd Trade On?
IND Swift Laboratories Ltd is listed and trades on the NSE stock exchange.
Is IND Swift Laboratories Ltd a Good Stock to Buy?
Determining whether Ind-Swift Labs (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
355.95
-16.75(-4.49%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
350.00
373.10
52 wk Range
87.15
389.50
ISLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
350.00373.10
52 wk Range
87.15389.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ISLB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
10/08/2026
EPS / Forecast
2.84 / --
Revenue / Forecast
1.91B / --
Compare ISLB to Peers and Sector
Metrics to compare | ISLB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipISLBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 54.0x | 35.7x | −0.4x | |
PEG Ratio | −0.68 | 0.30 | 0.00 | |
Price/Book | 2.2x | 4.9x | 2.6x | |
Price / LTM Sales | 4.6x | 3.9x | 3.0x | |
Upside (Analyst Target) | - | 6.8% | 48.7% | |
Fair Value Upside | Unlock | −1.3% | 7.0% | Unlock |
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson’s disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ind-Swift Labs (NSE: ISLB) Share Price Today?
The Ind-Swift Labs stock price today is 355.95 INR.
What Stock Exchange Does Ind-Swift Labs (ISLB) Trade On?
Ind-Swift Labs is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Ind-Swift Labs?
The stock symbol (also called a 'ticker') for Ind-Swift Labs is "ISLB."
What Is the Current Ind-Swift Labs Market Capitalisation?
As of today, Ind-Swift Labs (NSE: ISLB) market cap is 30.95B INR.
What Is Ind-Swift Labs's (ISLB) Earnings Per Share (TTM)?
The Ind-Swift Labs EPS is currently 6.47 (Trailing Twelve Months).
Is ISLB a Buy or Sell From a Technical Analyst Perspective?
Based on today's Ind-Swift Labs moving averages and other technical indicators, the daily buy/sell signal for ISLB stock is Strong Buy.
How Many Times Has Ind-Swift Labs Stock Split?
Ind-Swift Labs has split 0 times. (See the ISLB stock split history page for full effective split date and price information.)
How Many Employees Does Ind-Swift Labs Have?
Ind-Swift Labs has 1246 employees, based on their latest Companies House report.
What is the current trading status of Ind-Swift Labs (NSE: ISLB)?
As of 05/09/2026, Ind-Swift Labs (ISLB) is trading at a share price of 355.95 INR, with a previous close of 372.70 INR. The stock has fluctuated within a day range of 350.00 INR to 373.10 INR, while its 52-week range spans from 87.15 INR to 389.50 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.